Neuroblasztóma: vizsgálatok itt: Olaszország
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Milan, Rome, Turin
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - No phaseTaking peopleProspective Multicenter Study of the Genomic, Transcriptomic, and Biological Profile of Patients With Neuroblastoma
- Where
- Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro, Cosenza, Ferrara, Florence, Genova, Milan, Modena, Naples, Padova, Palermo, Parma, Pavia, Perugia, Pescara, Pisa, Reggio Calabria, Rimini, Roma, San Giovanni Rotondo, Sassari, Siena, Torino, Trieste, Verona
- Életkor
- 0 nap to 31 év
- People
- 200
- Run by
- Istituto Giannina Gaslini
See details and how to joinNCT07881172 - 1/2. fázisTaking peopleA phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
- Where
- Milan, Rome, Turin
- Életkor
- Up to 64 év
- People
- 72 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 · EU 2023-504880-18-00 - 1/2. fázisTaking peopleA Multi-Arm, Platform Trial For Relapsed Neuroblastoma
- Where
- Florence, Genoa, Milan, Padova, Rome, Turin
- Életkor
- 1 év to 64 év
- People
- 160 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00 - 1. fázisTaking peopleStudy Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
- Where
- Genoa, Rome
- Életkor
- 18 hónap to 18 év
- People
- 38 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00 - 3. fázisTaking peopleHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Where
- Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro, Firenze, Genoa, Milan, Modena, Naples, Padova, Palermo, Parma, Pavia, Perugia, Pescara, Pisa, Rimini, Rome, San Giovanni Rotondo, Torino, Trieste, Verona
- Életkor
- Up to 21 év
- People
- 800 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00 - 1/2. fázisTaking peoplePhase I/II study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric patients affected by High Risk and/or relapsed/refractory Neuroblastoma and other relapsed/refractory GD2+ tumors
- Where
- Rome
- Életkor
- Up to 64 év
- People
- 54
- Run by
- Ospedale Pediatrico Bambino Gesu
See details and how to join2024-520436-15-00 · EU 2024-520436-15-00 - 2. fázisTaking peopleTCRaß+CD19+ depleted haploidentical stem cell transplantation followed by immunotherapy in patients with relapsed/resistant high-risk neuroblastoma
- Where
- Genoa
- Életkor
- Up to 64 év
- People
- 19
- Run by
- IRCCS Istituto Giannina Gaslini
See details and how to join2024-519089-32-02 · EU 2024-519089-32-02